SANDRA FANTAUZZI: Open Payments
NPI 1982684205 · SEBRING, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$927 in 9 payments from 5 companies in 2025. Trend: 2023 $3,007 · 2024 $777 · 2025 $927
Consulting: $552Food & beverage: $375
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $662 |
| GENZYME CORPORATION | 1 | $124 |
| Novartis Pharmaceuticals Corporation | 4 | $74 |
| Galderma Laboratories, L.P. | 1 | $47 |
| Amgen Inc. | 1 | $19 |
Products named: DUPIXENT, Sotyktu, COSENTYX, OTEZLA, Rhapsido.
Industry payments across FL — which companies pay providers there.
